Neoadjuvant Systemic Therapy for Resectable Intrahepatic Cholangiocarcinoma: From Retrospective Studies to Randomized Evidence.

Suto H, Morishita A, Matsukawa H, Nagao M, Fuke T, Shimizu Y, Ando Y, Oshima M, Imado R, Nakahara M, Oura K, Tadokoro T, Fujita K, Tani J, Kobara H, Kumamoto K, Okano K

Open source

DOI
10.3390/cancers18172861
Published
2026 Sep 4
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18172861,
  title = {Neoadjuvant Systemic Therapy for Resectable Intrahepatic Cholangiocarcinoma: From Retrospective Studies to Randomized Evidence.},
  author = {Suto H and Morishita A and Matsukawa H and Nagao M and Fuke T and Shimizu Y and Ando Y and Oshima M and Imado R and Nakahara M and Oura K and Tadokoro T and Fujita K and Tani J and Kobara H and Kumamoto K and Okano K},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18172861},
  url = {https://doi.org/10.3390/cancers18172861}
}

RIS

TY  - JOUR
TI  - Neoadjuvant Systemic Therapy for Resectable Intrahepatic Cholangiocarcinoma: From Retrospective Studies to Randomized Evidence.
AU  - Suto H
AU  - Morishita A
AU  - Matsukawa H
AU  - Nagao M
AU  - Fuke T
AU  - Shimizu Y
AU  - Ando Y
AU  - Oshima M
AU  - Imado R
AU  - Nakahara M
AU  - Oura K
AU  - Tadokoro T
AU  - Fujita K
AU  - Tani J
AU  - Kobara H
AU  - Kumamoto K
AU  - Okano K
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18172861
UR  - https://doi.org/10.3390/cancers18172861
ER  - 

APA

H, S., A, M., H, M., M, N., T, F., Y, S., Y, A., M, O., R, I., M, N., K, O., T, T., K, F., J, T., H, K., K, K., & K, O. (2026). Neoadjuvant Systemic Therapy for Resectable Intrahepatic Cholangiocarcinoma: From Retrospective Studies to Randomized Evidence.. Cancers. https://doi.org/10.3390/cancers18172861

Source records